Related Experiment Video
Updated: Feb 21, 2026
09:31
Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
7.7K
Advances in pH-Sensitive Polymers for Smart Insulin Delivery.
Jing Xie1, Anqi Li1, Jianshu Li1,2
1College of Polymer Science and Engineering, Sichuan University, Chengdu, 610065, China.
Macromolecular Rapid Communications
|October 5, 2017
Summary
pH-sensitive polymers offer a promising approach for advanced insulin delivery systems. These materials enable controlled insulin release based on blood glucose levels, improving diabetes management.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Endocrinology
Background:
- Diabetes mellitus poses a significant global health challenge, necessitating improved blood glucose level (BGL) control.
- Traditional subcutaneous insulin injections face limitations in patient compliance and physiological mimicry.
- Alternative insulin delivery routes (oral, pulmonary, transdermal, nasal) are under investigation to enhance therapeutic outcomes.
Purpose of the Study:
- To review pH-sensitive polymers for controlled insulin delivery systems.
- To explore the relationship between polymer structure and insulin release performance.
- To highlight advancements in non-invasive diabetes management technologies.
Main Methods:
- Literature review of pH-sensitive polymers used in insulin delivery.
- Analysis of polymer conformational transitions in response to pH fluctuations.
- Evaluation of hydrogel swelling and insulin release mechanisms.
- Discussion of specific polymers like poly(2-dimethylamino)ethylmethacrylate) and chitosan.
Main Results:
- pH-sensitive polymers undergo conformational changes with pH variations, modulating hydrogel properties.
- These polymers facilitate controlled insulin release responsive to physiological BGL changes.
- Specific polymer structures significantly influence the efficiency and responsiveness of insulin delivery systems.
Conclusions:
- pH-sensitive polymers are effective candidates for developing smart insulin delivery systems.
- Tailoring polymer chemistry allows for precise control over insulin release kinetics.
- Further research into structure-property relationships can optimize these systems for improved diabetes care.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
36
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
36
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
32
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
32
01:27Insulin Formulations: Types and Delivery
841
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
841
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.6K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.6K
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
38
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
38
01:23Modified-Release Drug Delivery Systems: Classification
47
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
47